Inactive Instrument
TCR2 Therapeutics Inc. Share Price
Stocks
TCRR
US87808K1060
Biotechnology & Medical Research
| 1 day | -5.73% |
| Manager | Title | Age | Since |
|---|---|---|---|
William Bertrand
PSD | President | 61 | 31/05/2023 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Praveen Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/05/23 | Issuer sale | Director | 60,342 | 0.1537% | ||
| 31/05/23 | Issuer sale | Director | 53,868 | 0.1372% | ||
| 31/05/23 | Issuer sale | Head of Human Resources | 237,740 | 0.6055% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.73% | -15.43% | - | - | 58.11M | ||
| +1.08% | +8.57% | +3.61% | +9.34% | 49.92B | ||
| +0.40% | +4.34% | +401.69% | +606.81% | 40.23B | ||
| -0.52% | +7.76% | +25.41% | -6.76% | 34.55B | ||
| +3.97% | +10.56% | +26.06% | +61.61% | 33.09B | ||
| -4.19% | +6.03% | +3.76% | +32.17% | 27.51B | ||
| -2.40% | +2.75% | - | - | 17.05B | ||
| +1.34% | +7.21% | +75.77% | +138.54% | 15.92B | ||
| -0.95% | -0.38% | +12.92% | +17.96% | 13.86B | ||
| +1.69% | +2.46% | +93.44% | +97.16% | 13.52B | ||
| Average | -0.53% | +5.72% | +80.33% | +119.60% | 27.3B | |
| Weighted average by Cap. | +0.24% | +6.43% | +91.13% | +137.08% |
Employees
58
















